# Opsumit · 2,5 mg · Tabletki do sporządzania zawiesiny doustnej · 30 tabl. w blistrze perforowanym



## Poland

- **URPL** — [pl.dose-10060.org](https://pl.dose-10060.org)

## Codes

- **rpl-pack-id** — `159663`
- **eu-number** — `EU/1/13/893/004`

## Status

- **read** — 2026-11-15T02:02:49Z

## Holder

- Janssen-Cilag International N.V.

## Proof

Record pl:presentation:159663 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Opsumit 2.5 mg](https://dosidal.ai/pack/be/05413868125849) — BE — same product (EU central number)
- [OPSUMIT](https://dosidal.ai/pack/cz/0272851) — CZ — same product (EU central number)
- [Opsumit](https://dosidal.ai/pack/eu/EU-1-13-893-004) — EU — same product (EU central number)
- [OPSUMIT 2,5 MG DISZPERGÁLÓDÓ TABLETTA](https://dosidal.ai/pack/hu/210993566) — HU — same product (EU central number)
- [Opsumit 2.5 mg film-coated tablets](https://dosidal.ai/pack/ie/EU-1-13-893-004) — IE — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
